Inflammatory Bowel Diseases — A Self-compassion Intervention for Parents of Children With Inflammatory Bowel Disease (IBD)
Citation(s)
Breines JG, Chen S Self-compassion increases self-improvement motivation. Pers Soc Psychol Bull. 2012 Sep;38(9):1133-43. doi: 10.1177/0146167212445599. Epub 2012 May 29.
Neff, K D. (2003). Self-compassion: An alternative conceptualization of a healthy attitude toward oneself. Self and Identity, 2(2), 85-101. https://doi.org/10.1080/15298860309032
Neff, K D. (2003). The development and validation of a scale to measure self-compassion. Self and Identity, 2(3), 223-250. https://doi.org/10.1080/15298860309027
Sirois FM, Bögels S, Emerson LM Self-compassion Improves Parental Well-being in Response to Challenging Parenting Events. J Psychol. 2019;153(3):327-341. doi: 10.1080/00223980.2018.1523123. Epub 2018 Oct 30.
Watson, D , & Clark, L. A. (1994). The PANAS-X: Manual for the positive and negative affect schedule - expanded form. The University of Iowa. https://www2.psychology.uiowa.edu/faculty/clark/panas-x.pdf
A Self-compassion Intervention for Parents of Children With Inflammatory Bowel Disease (IBD)
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
